1. EichelbaumM,TestaB,SomogyiA, editors. Stereochemical aspects of drug action and disposition, Berlin: Springer; 2003.
2. EMEA. Investigation of chiral active substances. Report 3CC29a. EMEA; London; 1993. p 381-391.
3. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States;Miller;Chirality,2008
4. Miller S. Scientific and regulatory aspects of quality control for chiral drugs. Presented at 18th International Symposium on Chirality, Busan, 2006. Available at: www.fda.gov/cder/Offices/ONDQA/presentations/SMiller_Chirality_2006.pdf.